Navigation Links
Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
Date:10/17/2007

, Deloitte Consulting LLP, Deloitte Tax LLP, and their subsidiaries), and not by Deloitte & Touche USA LLP.

About the Deloitte Center for Health Solutions

The Deloitte Center for Health Solutions, based in Washington, D.C., is part of Deloitte & Touche USA LLP. The Center is a leading national source of objective and independent health care research. Its mission is to develop practical, innovative and workable solutions to the myriad health care issues affecting the U.S. public and private sectors. For additional information on the Center, please call 202-378-5278 or visit its website: http://www.deloitte.com/dtt/section_node/0,1042,sid%253D80772,00.html.

About the Nonprofit Roundtable

The Nonprofit Roundtable of Greater Washington was established in 2002 as a membership organization to build the strength influence and visibility of the nonprofit sector in Greater Washington. The Roundtable has 170 Members across the region, including direct service providers, advocacy organizations, and grant makers. By facilitating collaboration for regional solutions so that nonprofits can do more together, the Roundtable builds the capacity of nonprofit leadership within organizations serving communities in the District, Maryland, and Virginia. We achieve our mission through key initiatives and substantive Member events.

Contact:

David Thompson

Public Relations

Deloitte Services LP

o: (404) 942-6515

c: (678) 315-9493

davidthompson@deloitte.com


'/>"/>
SOURCE Deloitte
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
2. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
3. Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type Disasters; House Urged to Act on Strong Drug Safety Bill
4. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
5. New Study Shows That telmisartan has Greater Renoprotective Potential Thanlosartan in Hypertensive Patients With Type 2 Diabetes
6. Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
7. Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from 2006 Presented at Digestive Disease Week in Washington, D.C.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...Nov. 9 Cardiac Science...n automated external defibrillator ( AED ) and d...ced revenue of $38.9 million for the third quarter...us guidance. The Company also recorded a charge of... a non-cash charge of $44.0 million to increase it...
(Date:11/9/2009)...lands, Nov. 9 Momentum is buildin...third CPhI India and second P-MEC India pharma ing...ned total of over 600 exhibitors from over 80 ...Centre for the 2009 events, being held on 1 - 3 De...ors, the 2009 events include two new launches. Bi...
(Date:11/9/2009)... Patent attorneys Cheryl Liljestra...D., will showcase Stipkala LLC at the Texas Life S... be held at the Institute of Molecular Medicine in...rovides a platform for cutting-edge companies to i...and will feature keynote addresses and panel discu...
Breaking Medicine Technology:Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Forecast Looks Good for India Pharma Shows 2Forecast Looks Good for India Pharma Shows 3Roche Scientist Recognized for Excellence in Peptide Chemistry 5312 1Roche Scientist Recognized for Excellence in Peptide Chemistry 5312 2Roche Scientist Recognized for Excellence in Peptide Chemistry 5312 3Roche Scientist Recognized for Excellence in Peptide Chemistry 5312 4Scripps Pioneers Individualized Medicine by Offering Genetic Testing to Stent Patients 59104 1Scripps Pioneers Individualized Medicine by Offering Genetic Testing to Stent Patients 59104 2Scripps Pioneers Individualized Medicine by Offering Genetic Testing to Stent Patients 59104 3Scripps Pioneers Individualized Medicine by Offering Genetic Testing to Stent Patients 59104 4AUDIO from Medialink and OptumHealth 3A Learn How You Can Save Money on Healthcare this One Time of Year 59101 1
...severely-injured, acute cervical spinal cord... Mass., May 12 Alseres,Pharmaceuticals, Inc. (Nas...,from its Phase I/IIa clinical trial of Cethrin, a...estigated for its potential to restore motor and,s...The trial enrolled a,total of 48 patients of which...
...,biomaterials, medical device and tissue processin...of the combination aortic-mitral allograft heart,v...gery was performed by,Dr. Jose Navia, a cardiac su... Cleveland Clinic., The method used to process th...developed by CryoLife in collaboration with the Cl...
Other Medicine Technology:Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 2Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 3Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 5CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 2CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 3
(Date:11/9/2009)...vix helped men and women almost equally, study fin... -- The widely used clot-dissolving drug Plavix (c...n, an analysis of major clinical trials has found....dent in treating both men and women with this very...ctor of cardiovascular thrombosis at New York Univ...
(Date:11/9/2009)...rapy to improve letter formation could boost self-... 9 (HealthDay News) -- Autistic children are more ...uble forming letters, than those without autism, r...ldren, aged 8 to 13. Half of the study participant...ldren scored within the normal range for perceptua...
(Date:11/9/2009)..., SHENZHEN, China, Nov. 9 /PRNewswire-FirstCall/ ...l.com , announced today that Novartis, a US$41 bil...g an 85% stake in HTDS, H1N1 Vaccine partner, Zhej...$125 million. Novartis of Switzerland will begin a...ims: the company will dramatically increase its in...
(Date:11/9/2009)... New study highlights positi...h , Rosemont, IL (Vocus) ...se and bone health decreases. Recent research has ... supplements to help prevent these issues. However...ssue of Sports Health: A Multidisciplinary Approa...
(Date:11/9/2009)..., March of Dimes Names 2010 National Ambassador...Newswire/ -- Joshua Hoffman of Weston, Fla., was b...s that doctors could not say whether he would surv.... Today, the 6-year-old was named March of Dimes 2...nie Hoffman, recalls, "My first minutes of motherh...
Breaking Medicine News(10 mins):Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3
...20, 2008)Documenting a twofold to fivefold increas...istent sleeplessness, public health researchers at...Houston say they have completed the first prospect...ptoms of insomnia and almost half of these youngst...
...rch 21 MEDai, Inc., headquartered in,Orlando, FL,...thcare that,utilize award-winning predictive analy...across the US maximize the benefits of predictive ...workshop that helps organizations focus on how the...
... recent survey by the Harvard School of Public Hea...r ongoing series, Debating Health: Election 2008, ...sue of whether the United States has the best heal...swer) and that there is a significant divide along...
... Antibodies protect against bacteria in the blood ...hoidal strains of Salmonella bacteria (NTS) usuall...es gastroenteritis. By contrast, in Africa, childr...hildren. There is currently no vaccine against NTS...
....Y., March 20 XTL,Biopharmaceuticals Ltd. (Nasdaq...engaged in the acquisition and development of ther... particularly diabetic neuropathic pain,and hepati...short-,term bank deposits of $13.0 million, compar...
...action helps form ozone haze, scientists say , ...ists say they,ve identified a chemical reaction th...ical reaction -- which involves reactions between ...an Diego, conclude that it,s actually a major cont...
Other Medicine News:Health News:Adolescents with chronic insomnia report 'twofold to fivefold' increase in personal problems 2Health News:MEDai Assists Healthcare Organizations Demonstrate the Value of Predictive Modeling 2Health News:Most republicans think the US health care system is the best in the world; democrats disagree 2Health News:Most republicans think the US health care system is the best in the world; democrats disagree 3Health News:JCI table of contents: March 20, 2008 2Health News:JCI table of contents: March 20, 2008 3Health News:JCI table of contents: March 20, 2008 4Health News:JCI table of contents: March 20, 2008 5Health News:XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007 2Health News:XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007 3Health News:XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007 4Health News:XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007 5Health News:XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007 6Health News:Smog's Origins Get Clearer 2
Reciprocating Platelet Shaker TPS-16
...ogesterone is a steroid produced by the adrenal co...ta. As with other steroids, progesterone is synthe...ated steps [1,2]. Progesterone produced by the adr...ed into other steroidogenic pathways, with only a ...
Insulin IRMA Kit
Insulin ELISA Kit
Medicine Products: